Valganciclovir for the prophylaxis of early cytomegalovirus (CMV) infection after allogeneic stem cell transplantation

被引：0
|
作者：
Bachier, C
Shaughnessy, P
Wall, D
Grimley, M
Carrum, G
Freytes, C
Callander, N
Walsh, T
LeMaistre, CF
机构：
[1] Texas Transplant Inst, San Antonio, TX USA
[2] Ctr Cellular & Gene Therapy, Houston, TX USA
[3] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.267
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
267
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
  • [1] Valganciclovir for the early prophylaxis of cytomegalovirus (CMV) infection after allogeneic stem cell transplantation.
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    [J]. BLOOD, 2004, 104 (11) : 352B - 352B
  • [2] Cytomegalovirus (CMV) infection after allogeneic stem cell transplantation (SCT)
    Trenschel, R
    Ross, S
    Runde, V
    Retzlaff, S
    Ottinger, H
    Kohl, D
    Roggendorf, M
    Schaefer, UW
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S68 - S68
  • [3] Valganciclovir is effective in the preemptive treatment of cytomegalovirus (CMV) infection after allogeneic stem cell transplant (ASCT)
    Aberle, MF
    Bachier, C
    Lemaistre, FC
    Shaughnessy, PJ
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 136 - 136
  • [4] Pre-emptive therapy with valganciclovir for cytomegalovirus (CMV) infection after allogeneic haematopoietic stem cell transplantation (Allo-HSCT)
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Ilhan, O.
    Akan, H.
    Uysal, A.
    Gurman, G.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S322 - S323
  • [5] Treatment of cytomegalovirus infection with oral valganciclovir in allogeneic haematopoietic stem cell transplantation
    Uresandi, A
    Bermudez, A
    Yañez, L
    Gonzalez-Mesones, B
    Puente, M
    Baro, J
    Conde, E
    Iriondo, A
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S187 - S187
  • [6] High dose acyclovir for cytomegalovirus infection prophylaxis after allogeneic stem cell transplantation
    Iannella, E.
    Lori, A. P.
    Torelli, G. F.
    Milano, F.
    Capobianchi, A.
    Lucarelli, B.
    Malandruccolo, L.
    Valle, V.
    Arleo, E.
    Martino, P.
    Foa, R.
    Gentile, G.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 103 - 103
  • [7] The influence of valganciclovir prophylaxis on cytomegalovirus, infection after lung transplantation
    Hellemons, M. E.
    van der Bij, W.
    Erasmus, M. E.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S104 - S104
  • [8] PROPHYLAXIS OF CMV INFECTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH NILOTINIB : A PHASE II TRIAL
    Lin, C. T.
    Wu, S. J.
    Li, C. C.
    Ko, B. S.
    Yao, M.
    Lin, W. P.
    Tang, J. L.
    Tien, H. F.
    [J]. HAEMATOLOGICA, 2014, 99 : 423 - 423
  • [9] Cidofovir (CDV) as prophylaxis and pre-emptive therapy of Cytomegalovirus (CMV) infection in allogeneic stem cell transplantation
    Cudillo, L
    Dentamaro, T
    Postorino, M
    Picardi, A
    Rainaldi, A
    Cupelli, L
    De Laurenzi, F
    Di Caro, A
    Amadori, S
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S153 - S153
  • [10] Extension of CMV prophylaxis possible after allogeneic stem cell transplantation
    Freyer, Martina
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (04) : 162 - 162
12345